Atrial Functional Mitral Regurgitation and Tricuspid Regurgitation
Recruiting · NCT05920824 · Observational (researchers observe without assigning treatment) · Lead sponsor: Barts & The London NHS Trust
View the official record on ClinicalTrials.gov →Interventions studied
Echocardiogram
What this trial is about
A prospective, observational cohort study designed to identify clinical phenotypes and evaluate predictors \& outcomes of functional mitral and tricuspid valve regurgitation in patients with atrial fibrillation. Participant will under go: * Baseline echocardiography * Cpex Echocardiography * Blood test: BNP * 1 year follow up Echocardiography Participants will be stratified into three subgroups: * Atrial Functional MR * Atrial Functional TR * Mixed MR \& TR
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Informed consent
- Age of 18 years or older
- Atrial fibrillation
- Moderate or severe atrial valve disease
- Adequate 2D echocardiography views including parasternal long axis, short axis, apical two chamber, apical three chamber and four chamber.
Exclusion criteria
- Unwilling or unable to give consent
- Left ventricular impairment (ejection fraction \< 50%).
- Primary/organic valve disease
Where it is running
1 location listed.
- St Bartholomew's Hospital - London, United Kingdom